Q&A: Patients with NAFLD-related cirrhosis, high BMI, psychiatric disease likely to use opioids

Opioid use was more common in patients with nonalcoholic fatty liver disease with cirrhosis, higher BMI and psychiatric disease, according to a study published in Digestive Diseases.Healio Gastroenterology spoke with Andrew M. Moon, MD, advanced/ transplant hepatology at the University of North Carolina, about the TARGET-NASH study looking at opioid use in 3,474 patients with NAFLD.Healio: What was the purpose of the study?Moon: We knew that the burden of NAFLD was huge in the United States and we knew from clinical experience that patients with this condition experience painfulRead More